Prostamax: research, legal status and who sells it
This page is information, not medical advice. Prostamax is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.
- Also known as
- Lys-Glu-Asp-Pro, KEDP peptide, Prostomax
- Category
- Synthetic tetrapeptide (Khavinson peptide bioregulator)
- Evidence level
- Preclinical (lab and animal studies)
- Price range
- $1.00/mg to $5.25/mg, median $3.00/mg across 11 vendors (compare)
- Our lab tests
- None yet (how testing will work)
Legal and regulatory status
| Where | Status |
|---|---|
| United States | No FDA-approved drug contains prostamax [1]. |
| United Kingdom | No UK-licensed medicine containing prostamax appears in the MHRA products database [2]. |
| European Union | No medicine containing prostamax is authorized in the EU, according to EMA's central and Article 57 product data [3][4]. |
| Canada | No product containing prostamax appears in Health Canada's Drug Product Database [5]. |
| Australia | Prostamax is not named in Australia's Poisons Standard (October 2026) [6]. |
| Sport (WADA) | Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7]. |
We haven't published a full overview of Prostamax yet. The legal status table and live prices on this page are current.
Prostamax prices: cheapest listings
The five lowest $/mg listings out of 11. See all Prostamax prices
| Vendor | Transparency | Product | Size | Price | $/mg | Stock | Vendor's page |
|---|---|---|---|---|---|---|---|
| Bulk Peptide Wholesale | 45 | 20 mg × 10 | $200 | $1.00/mg | View | ||
| Bulk Peptide Supply | 57 | 20 mg × 10 | $375 | $1.88/mg | View | ||
| Peptide Crafters | 27 | 25 mg | $55 | $2.20/mg | View | ||
| Modern Aminos | 77 | 20 mg | $54 | $2.70/mg | View | ||
| Pure Lab Peptides | 82 | 20 mg | $55 | $2.75/mg | Out of stock | View |
Sources
- Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
- MHRA Products: licensed-medicine search for "prostamax". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
- EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
- Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
- Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
- World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
- Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences (2022). Accessed Oct 15, 2026
- Deheterochromatinization of the chromatin in old age induced by oligopeptide bioregulator (Lys-Glu-Asp-Pro) (in Russian). Georgian Medical News (2012). Accessed Oct 15, 2026